Skip to content
HUB Organoids
services
services overview
drug screening
model and assay development
clinical trials in a dish
technology
company
about us
careers
events
latest news
resources
license program
contact
Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient response
J Exp Clin Cancer Res | 2024 Feb
X
Have any questions?
